| 000 | 01073 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517022941.0 | ||
| 264 | 0 | _c20150424 | |
| 008 | 201504s 0 0 fre d | ||
| 022 | _a0370-629X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJerusalem, G | |
| 245 | 0 | 0 |
_a[The drug of the month: everolimus (Afinitor) for the treatment of metastatic breast cancer]. _h[electronic resource] |
| 260 |
_bRevue medicale de Liege _cSep 2014 |
||
| 300 |
_a510-7 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 700 | 1 | _aRorive, A | |
| 700 | 1 | _aCollignon, J | |
| 773 | 0 |
_tRevue medicale de Liege _gvol. 69 _gno. 9 _gp. 510-7 |
|
| 999 |
_c24730339 _d24730339 |
||